BAGSVAERD, DENMARK--(Marketwire - January 02, 2013) - In continuation of the company's
announcements dated 9 August 2012 and 9 November 2012 concerning planned
share repurchase programmes, and pursuant to Section 204.25 of the New York
Stock Exchange Listed Company Manual, this is to report that Novo Nordisk
A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2012 owned
17,416,676 of its own B shares of DKK 1, corresponding to a total nominal
value of DKK 17,416,676 or 3.1% of the total share capital.
Company announcement No 02 / 2013:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE